IGRYPH

Welcome to the Brand page for “IGRYPH”, which is offered here for Pharmaceutical preparations for use in infectious diseases, viral diseases, cancer, autoimmune diseases, central nervous system disorders, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders, oncological conditions, ophthalmologic diseases, respiratory diseases, thrombotic diseases, vascular diseases, and inflammation;.

Its status is currently believed to be active. Its class is unavailable. “IGRYPH” is believed to be currently owned by “HUMAN GENOME SCIENCES, INC.”